Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program

European Journal of Epidemiology

Volumn 22, Issue 7, 2007, Pages 447-455

  Hofvind, Solveig ^a,b   Geller, Berta ^b   Vacek, Pamela M ^b   Thoresen, Steinar ^a   Skaane, Per ^c,d  

^a Cancer Registry of Norway ^*  (Norway)

^b UNIVERSITY OF VERMONT   (United States)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Breast cancer screening; Interval cancer; Mammography; Surrogate measures

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; EUROPE; FEMALE; HEALTH PROGRAM; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; MORTALITY; PRACTICE GUIDELINE; RISK REDUCTION; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; EARLY DIAGNOSIS; EUROPE; FEMALE; GOVERNMENT PROGRAMS; GUIDELINE ADHERENCE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NORWAY; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES; PROGRAM EVALUATION; REGISTRIES;

EID: 34547676816     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-007-9137-y     Document Type: Article

References (27)

1. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am 2004;42:793-806.
2. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19.
3. Vainio H, Bianchini F (editors). IARC handbook of cancer prevention. vol 7: breast cancer screening. IARCPress: Lyon, France; 2002, http://www.iarc.fr.
4. Gøtzche P, Nielsen M. Screening for breast cancer with mammography (review).vol 4. The Cochrane Library, John Wiley & Sons Ltd.; 2006.
5. Swedish Organized Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
6. Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet 2003;361:1411-7.
7. Perry N, Broeders M, deWolf C, Törnberg S, Holland R, von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. European Communities: Printed in Belgium; 2006. http://europa.eu.int.
8. Sarkeala T, Anttila A, Saarenmaa I, Hakama M. Validity of process indicators of screening for breast cancer to predict mortality reduction. J Med Screen 2005;12:33-7.
9. Tingulstad S, Halvorsen T, Norstein J, Hagen B, Skjeldestad FE. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway. Int J Cancer 2002;98:907-11.
10. The Ministry of Health and Social Affairs, Oslo. Regulations on the collections and processing of the personal health data in the Cancer Registry of Norway (Cancer Registry Regulations). The Ministry of Health and Social Affairs: Oslo, Norway; 2001.
11. Hofvind S. Breast cancer screening-prevalence of disease in women who only attend after an invitation reminder. J Med Screen 2007;14:21-2.
12. Ottestad PM. IT solutions in a centrally organized mammography screening in Norway. Med Informatics Europe 1996;34:54-7.
13. Norsk Bryst Cancer Gruppe. Breast cancer-diagnostics and treatment. Brystkreft- Diagnostikk og behandling: In Norwegian. 2007. http://www.nbcg.net.
14. Thurfjell E. Mammography screening methods and diagnostic results. Acta Radiol Suppl 1995;395:1-22.
15. Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K. Comparing the performance of mammography screening in the USA and the UK. J Med Screen 2005;12:50-4.
16. Rimer BK, Bluman LG. The psychosocial consequences of mammography. J Natl Cancer Inst Monogr 1997;22:131-8.
17. Yankaskas BC, Cleveland RJ, Schell MJ, Kozar R. Association of recall rates with sensitivity and positive predictive values of screening mammography. AJR Am J Roentgenol 2001;177:543-9.
18. Yankaskas BC, Klabunde CN, Ancelle-Park R, Renner G, Wang H, Fracheboud J, et al. International comparison of performance measures for screening mammography: can it be done? J Med Screen 2004;11:187-93.
19. Thurfjell E. Mammography screening. One versus two views and independent double reading. Acta Radiol 1994;35:345-50.
20. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
21. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-29.
22. Weedon-Fekjaer H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen 2005;12:172-8.
23. Zahl PH, Strand BH, Maelen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921-4.
24. Olsen AH, Agbaje OF, Myles JP, Lynge E, Duffy SW. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006;12:338-42.
25. Hofvind S, Skaane P, Vitak B, Wang H, Thoresen S, Eriksen L, et al. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program. Radiology 2005;237:437-43.
26. Hofvind S, Bjurstam N, Sørum R, Bjorndal H, Thoresen S, Skaane P. Number and characteristics of breast cancer diagnosed in four periods in the screening interval of a biennial population based screening program. J Med Screen 2006;13:192-6.
27. Bordas P, Jonsson H, Nyström L, Lenner P. Survival from invasive breast cancer among interval cancers in the mammography screening programmes of northern Sweden. The Breast 2007;16: 47-54.